Latest Updates

The company received a warning letter from the United States Food and Drug Administration (US FDA) related to their unit XI,…

HOWARU Protect Prenatal+, formulated with L. acidophilus La-14 in combination with L. rhamnosus HN001, may help provide full-body…

The drug, Clindamycin Phosphate Foam, 1 per cent, is a generic version of Mylan Pharmaceuticals' Evoclin Foam

Expansion enhances the company’s ability to serve the growing ADC market Piramal Pharma Solutions (PPS), a leading Contract…

The plant has received an establishment inspection report (EIR). The EIR report stated that the classification of the facility is…

Lynparza can now be used in patients who are in response following chemotherapy for advanced BRCA-mutated ovarian cancer in…

Rozlytrek aims to treat people with a rare genetic anomaly, called NTRK fusions, that drive growth in a range of tumours found…

In the event, Agilent showcased its latest analytical solutions and applications, featured experts as speakers and conducted…

Data sets will be used to improve the understanding of key diseases and extract patients’ insights and feedback French healthcare…

The company has fixed July 1, 2019, as the expected date of completion of the sale